Biologically Active Small Molecules

A specific antagonist of the type 4 PGE2 receptor EP4 possesses significant anti-tumor growth activity in multiple preclinical tumor models through modulating myeloid cells.

A specific antagonist of the type 4 PGE2 receptor EP4 possesses significant anti-tumor growth activity in multiple preclinical tumor models through modulating myeloid cells.

A specific antagonist of the type 4 PGE2 receptor EP4 possesses significant anti-tumor growth activity in multiple preclinical tumor models through modulating myeloid cells.

A quinone derivative that inhibits red blood cell PLA2 with a Ki value of 130 &microM.

A quinone derivative that inhibits red blood cell PLA2 with a Ki value of 130 &microM.

A quinone derivative that inhibits red blood cell PLA2 with a Ki value of 130 &microM.

A quinone derivative that inhibits red blood cell PLA2 with a Ki value of 130 &microM.

All of our Earle&rsquos Balanced Salt Solution contains: Potassium Chloride, Sodium Chloride, Sodium Phosphate Monobasic, and D-glucose. Some formulations may contain additional components.

A histamine H1 receptor antagonist (Ki = 0.4 nM IC₅₀ = 45 nM) that does not cross the blood brain barrier 10 &muM inhibits T cell proliferation and the production of Th2-type pro-inflammatory cytokines by macrophages.

A histamine H1 receptor antagonist (Ki = 0.4 nM IC₅₀ = 45 nM) that does not cross the blood brain barrier 10 &muM inhibits T cell proliferation and the production of Th2-type pro-inflammatory cytokines by macrophages.

A histamine H1 receptor antagonist (Ki = 0.4 nM IC₅₀ = 45 nM) that does not cross the blood brain barrier 10 &muM inhibits T cell proliferation and the production of Th2-type pro-inflammatory cytokines by macrophages.

A &beta-lactone that stimulates host defense in immune cells by inhibiting cell surface esterases, lipases, and N-formylmethionine aminopeptidases with IC₅₀ values of 0.056, 0.